Lantheus Holdings, Inc. Operating Cash Flow
Lantheus Holdings, Inc. (LNTH) reported Operating Cash Flow of $217.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $92.20M, a 5.85% increase year-over-year.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $125.13M, a 16.33% increase year-over-year.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $90.18M, a 42.83% decline year-over-year.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $105.29M, a 39.85% decline year-over-year.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $390.14M, a 28.38% decline from fiscal 2024.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $544.75M, a 78.45% increase from fiscal 2023.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $305.26M, a 8.33% increase from fiscal 2022.
- Lantheus Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $281.78M, a 422.63% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $92.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $217.33M 10-Q · filed 2026-08-06 | $307.51M derived: sum of 3 quarters · filed 2026-08-06 | $412.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $125.13M 10-Q · filed 2026-05-07 | $215.31M derived: sum of 2 quarters · filed 2026-05-07 | $320.60M derived: sum of 3 quarters · filed 2026-05-07 | $407.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $90.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $195.47M derived: sum of 2 quarters · filed 2026-02-26 | $282.58M derived: sum of 3 quarters · filed 2026-08-06 | $390.14M 10-K · filed 2026-02-26 |
| 2025-09-30 | $105.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $192.40M derived: sum of 2 quarters · filed 2026-08-06 | $299.96M 10-Q · filed 2025-11-06 | $457.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $87.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $194.67M 10-Q · filed 2026-08-06 | $352.40M derived: sum of 3 quarters · filed 2026-08-06 | $527.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $107.56M 10-Q · filed 2026-05-07 | $265.29M derived: sum of 2 quarters · filed 2026-05-07 | $440.36M derived: sum of 3 quarters · filed 2026-05-07 | $525.08M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $157.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $332.79M derived: sum of 2 quarters · filed 2026-02-26 | $417.51M derived: sum of 3 quarters · filed 2026-02-26 | $544.75M 10-K · filed 2026-02-26 |
| 2024-09-30 | $175.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $259.78M derived: sum of 2 quarters · filed 2025-11-06 | $387.02M 10-Q · filed 2025-11-06 | $499.31M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $84.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $211.96M 10-Q · filed 2025-08-06 | $324.25M derived: sum of 3 quarters · filed 2026-02-26 | $440.98M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $127.24M 10-Q · filed 2025-05-07 | $239.53M derived: sum of 2 quarters · filed 2026-02-26 | $356.26M derived: sum of 3 quarters · filed 2026-02-26 | $324.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $112.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $229.03M derived: sum of 2 quarters · filed 2026-02-26 | $196.76M derived: sum of 3 quarters · filed 2026-02-26 | $305.26M 10-K · filed 2026-02-26 |
| 2023-09-30 | $116.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $84.47M derived: sum of 2 quarters · filed 2024-11-06 | $192.97M 10-Q · filed 2024-11-06 | $298.32M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$32.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $76.23M 10-Q · filed 2024-07-31 | $181.59M derived: sum of 3 quarters · filed 2025-02-26 | $275.15M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $108.50M 10-Q · filed 2024-05-02 | $213.85M derived: sum of 2 quarters · filed 2025-02-26 | $307.42M derived: sum of 3 quarters · filed 2025-02-26 | $380.02M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $105.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $198.92M derived: sum of 2 quarters · filed 2025-02-26 | $271.52M derived: sum of 3 quarters · filed 2025-02-26 | $281.78M 10-K · filed 2025-02-26 |
| 2022-09-30 | $93.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $166.16M derived: sum of 2 quarters · filed 2023-11-02 | $176.43M 10-Q · filed 2023-11-02 | $190.32M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $72.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $82.86M 10-Q · filed 2023-08-03 | $96.75M derived: sum of 3 quarters · filed 2024-02-22 | $101.09M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $10.26M 10-Q · filed 2023-05-04 | $24.15M derived: sum of 2 quarters · filed 2024-02-22 | $28.49M derived: sum of 3 quarters · filed 2024-02-22 | $54.36M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $18.23M derived: sum of 2 quarters · filed 2024-02-22 | $44.10M derived: sum of 3 quarters · filed 2024-02-22 | $53.92M 10-K · filed 2024-02-22 |
| 2021-09-30 | $4.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $30.21M derived: sum of 2 quarters · filed 2022-11-03 | $40.03M 10-Q · filed 2022-11-03 | $40.60M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $25.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $35.69M 10-Q · filed 2022-08-04 | $36.26M derived: sum of 3 quarters · filed 2023-02-23 | $44.83M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $9.82M 10-Q · filed 2022-04-29 | $10.39M derived: sum of 2 quarters · filed 2023-02-23 | $18.96M derived: sum of 3 quarters · filed 2023-02-23 | $16.81M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $9.14M derived: sum of 2 quarters · filed 2023-02-23 | $6.99M derived: sum of 3 quarters · filed 2023-02-23 | $16.40M 10-K · filed 2023-02-23 |
| 2020-09-30 | $8.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.42M derived: sum of 2 quarters · filed 2021-11-04 | $15.83M 10-Q · filed 2021-11-04 | $38.25M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $7.25M 10-Q · filed 2021-07-28 | $29.67M derived: sum of 3 quarters · filed 2022-02-24 | $56.12M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $9.41M 10-Q · filed 2021-05-04 | $31.83M derived: sum of 2 quarters · filed 2022-02-24 | $58.27M derived: sum of 3 quarters · filed 2022-02-24 | $79.32M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $22.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $48.86M derived: sum of 2 quarters · filed 2022-02-24 | $69.92M derived: sum of 3 quarters · filed 2022-02-24 | $80.38M 10-K · filed 2022-02-24 |
| 2019-09-30 | $26.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $47.49M derived: sum of 2 quarters · filed 2020-11-05 | $57.96M 10-Q · filed 2020-11-05 | $75.27M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $21.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $31.52M 10-Q · filed 2020-07-31 | $48.83M derived: sum of 3 quarters · filed 2021-02-25 | $73.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $10.47M 10-Q · filed 2020-04-30 | $27.77M derived: sum of 2 quarters · filed 2021-02-25 | $52.05M derived: sum of 3 quarters · filed 2021-02-25 | $72.33M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $17.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $41.58M derived: sum of 2 quarters · filed 2021-02-25 | $61.86M derived: sum of 3 quarters · filed 2021-02-25 | $61.19M 10-K · filed 2021-02-25 |
| 2018-09-30 | $24.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $44.55M derived: sum of 2 quarters · filed 2019-10-31 | $43.89M 10-Q · filed 2019-10-31 | $56.97M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $20.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $19.61M 10-Q · filed 2019-07-25 | $32.70M derived: sum of 3 quarters · filed 2020-02-25 | $48.30M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$666.00K 10-Q · filed 2019-04-30 | $12.42M derived: sum of 2 quarters · filed 2020-02-25 | $28.02M derived: sum of 3 quarters · filed 2020-02-25 | $48.59M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $13.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $28.69M derived: sum of 2 quarters · filed 2020-02-25 | $49.25M derived: sum of 3 quarters · filed 2020-02-25 | $54.78M 10-K · filed 2020-02-25 |
| 2017-09-30 | $15.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $36.17M derived: sum of 2 quarters · filed 2018-10-30 | $41.69M 10-Q · filed 2018-10-30 | $54.47M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $20.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $26.09M 10-Q · filed 2018-08-01 | $38.87M derived: sum of 3 quarters · filed 2019-02-20 | |
| 2017-03-31 | $5.52M 10-Q · filed 2018-05-02 | $18.30M derived: sum of 2 quarters · filed 2019-02-20 | ||
| 2016-12-31 | $12.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $49.64M 10-K · filed 2019-02-20 | ||
| 2016-09-30 | $36.86M 10-Q · filed 2017-11-02 | |||
| 2015-12-31 | $21.76M 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |